First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome ... ( Partners Analyze Jatropha Genome and ...)

First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology

Date:5/20/2009

Partners Analyze Jatropha Genome and Associated Microbial Genomes to Understand and Improve Plant Yield and Health to Develop Renewable Fuels, Biofertlizers, and Disease Control Solutions

Jatropha Genome Represents Second Milestone Accomplishment for Partners who Announced Complete Oil Palm Genome Sequence in 2008

LA JOLLA, Calif. and KUALA LUMPUR, Malaysia, May 20 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company applying genomic-driven commercial solutions to address global issues, and Asiatic Centre for Genome Technology (ACGT), a company focused on the commercial application of genome technology to improve oil palm and other crops, today announced completion of a first draft, 10X assembly of the jatropha genome. The completed jatropha genome represents another significant milestone in the ongoing joint venture between ACGT and SGI announced in 2007. The partners previously announced completion of the oil palm genome in 2008. ACGT is a wholly owned subsidiary of Asiatic Development Berhad, an oil palm plantation company and a member of the Genting Group.

ACGT and SGI have focused on Jatropha for several reasons: it is a tropical tree that is one of the highest yielding oilseed plants in the world; it can be grown on marginal, non-food producing lands; has a very short generation time; can be productive for 30 to 40 years; and its seed oil and biomass are ideal for biofuel production. Jatropha is a non-domesticated plant which makes it an ideal subject for genetically engineered improvements.

The sequencing of the genome, using both traditional Sanger sequencing and next generation sequencing, has revealed that the jatropha genome is approximately 400 million base pairs in size, similar to the size of the rice genome. The teams are now working on annotating the genome to identify particular genes of interest and to discover genetic variations for use in marker assi
'/>"/>

SOURCE Synthetic Genomics Inc.
Copyright©2009 PR Newswire.
All rights reserved

4

GOOD

Page: 1 2 3
Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD

Post Your Comments:

(Date:11/23/2009)...Newswire-USNewswire/--FebeDurango-Rueda,52,aColomb...tinginaschemetodefraudtheExport-ImportBankoftheUni...ssistantAttorneyGeneraloftheCriminalDivisionLannyA...ftheEx-ImBank,OfficeoftheInspectorGeneral. ,, D...S.DistrictCourtinWashingtontoaone-countcriminalinf...

(Date:11/23/2009)...PRNewswire-FirstCall/--Immucor,Inc.(Nasdaq: BLUD )...ntsystemstothebloodtransfusionindustry,todayannoun...tAnnualHealthCareConferenceinNewYork,NYwillbeavail...,spresentationisscheduledforTuesday,December1,2009...lbeavailablethroughthe"AboutUs--InvestorInformatio...

(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--Amgen(Nasdaq: AMGN )...rallPipelineandforBestNewDrugforNplate®(romip...erallPipelineawardwaspresentedtoAmgenbyScripinreco...ofthecompany,spipeline,aswellasitsmixofcandidatesa...spipelineisnotableforitsfocusonunmetclinicalneed. ...

Breaking Medicine Technology:Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million 2 Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2 Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3 Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4 Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5 Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6 First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 1 First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 2 First Results From Major European Patient Survey Show Devastating Impact of Living With Breakthrough Cancer Pain 56504 3 Small businesses would see lower costs more comprehensive coverage from health reform 56501 1 Small businesses would see lower costs more comprehensive coverage from health reform 56501 2 Small businesses would see lower costs more comprehensive coverage from health reform 56501 3 Sinapis Pharma Announces Frederick Frank as Consultant 56499 1 Sinapis Pharma Announces Frederick Frank as Consultant 56499 2

[0] Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million [0] Immucor to Present at the Piper Jaffray 21st Annual Health Care Conference [0] Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards

...nced Solid Tumors, Including Lung Cancer, SAN FRA...and Ottawa, Canada) today announced the completion...Phase 1 cancer clinical trial of its targeted,poxv...n. No significant,toxicities were reported, and tr... involves treatment of patients with advanced,meta...

...nformatics, one,of the industry,s leading eClinica... International Corporation (Nasdaq: PRXL ), annou...solution, a specialized Clinical Trial,Management ...mid-size,companies. The enhanced 2.1 version of th...r reporting, data transfer, and analyzing study,in...

Other Medicine Technology:Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus 2 Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus 3 Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution 2 Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution 3 Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution 4 Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution 5

Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution

(Date:11/23/2009)...3, 2009) -- A first-of-its-kind consensus statemen... the Annals of Surgery . The report illustrates t...onference -- Diabetes Surgery Summit (DSS) -- wher...c and medical experts agreed on a set of evidence-... guide the use and study of gastrointestinal surge...

(Date:11/23/2009)...y, first woman to head the agency, said lives coul...Day News) -- The fallout from last week,s controve... routine mammogram testing for breast cancer conti...itutes of Health advising women to ignore the guid...em, because unequivocally this will increase the n...

(Date:11/23/2009)...ipswithMinorityBanksin Washington D.C. , New...mbia , S.C. IntendedtoSpurEconomicGrowthandRevi...ewswire/--DaVita,thenation,sleadingproviderofdialy...nitiativedesignedtocreatejobsandspurrevitalization...tsinleadingcommunityandminority-ownedbanks.DaVitah...

(Date:11/23/2009)...,Nov.23/PRNewswire-USNewswire/-- The AmericanLegi...dividualmembershipassociationofstatelegislators,co...tt forpre-filinga constitutionalamendment toprotec...ces.SouthCarolinanowbecomesthe24thstatewherelegisl...eledafterALEC,s FreedomofChoiceinHealthCareAct . ,...

(Date:11/23/2009)...v.23/PRNewswire/--Howistheeconomyaffectingpeople,s...hiWellnessonWellness&theEconomy,theeconomyisma...healthylifestyleofexerciseanddiettoonethatismorein..., Thesurvey,smostdramaticfindingwasthechangeinco...itionalfocusonhealthandwellbeingtotoday,smorerelev...

Breaking Medicine News(10 mins):Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 2 Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 3 Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 4 Health News:Diabetes surgery summit consensus lays foundation for new field of medicine 5 Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 2 Health News:Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says 3 Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2 Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3 Health News:South Carolina Now 24th State to Defend Health Care Choice 2 Health News:Being Well Is About Reinvention - Not Health 2 Health News:Being Well Is About Reinvention - Not Health 3

[1] Diabetes surgery summit consensus lays foundation for new field of medicine [1] Women Should Ignore New Mammogram Guideline, Ex-NIH Chief Says [0] DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country [1] South Carolina Now 24th State to Defend Health Care Choice [0] Being Well Is About Reinvention - Not Health

...al Lifeline for Americans Struggling With Serious ...Insurance Company of America (Guardian) supports N...ilies, business owners, benefits decision makers a...ional Stroke Association, stroke is the number one...

...es new "E" tool for detecting melanoma , , SCHAU...ch or backyard barbeques is a great way to honor t...ican Academy of Dermatology (Academy) hopes more f...ally melanoma (the deadliest form of skin canc...

...m Noblis Health Innovation, a leading non-profit a...e context of the current economic crisis, nearly a...affiliation than a year ago. Conducted in April 2... leading health care executives who have agreed to...

...ldiers, get to the site of infection or injury? T...of the blood vessel gripping it tightly to avoid ...searching for temporary ,road signs, made of speci...ished in the journal Immunity , Prof. Ronen Alon ...

...e to delay in treatment for women, signal need to ...OR, Mich., May 4 The traditional stroke symptoms ...ess or weakness on one side of the body, trouble t...Lisabeth, Ph.D., MPH, researcher in the department...

...tago,s Inventory of Infringing Products - , , ,... Company and its parent company Instrumentation La...s First Level Civil Court determined that Diagnost...ating advertisements. As a result, the Court ruled...

Other Medicine News:Health News:Guardian Highlights Significance of Critical Illness Insurance During National Stroke Awareness Month 2 Health News:Guardian Highlights Significance of Critical Illness Insurance During National Stroke Awareness Month 3 Health News:Guardian Highlights Significance of Critical Illness Insurance During National Stroke Awareness Month 4 Health News:Dermatologists Encourage People to Screen the One You Love for Skin Cancer 2 Health News:Dermatologists Encourage People to Screen the One You Love for Skin Cancer 3 Health News:Dermatologists Encourage People to Screen the One You Love for Skin Cancer 4 Health News:Dermatologists Encourage People to Screen the One You Love for Skin Cancer 5 Health News:Noblis Insights Panel Finds Growing Interest in Hospital Affiliation as a Strategic Response to Challenging Market Conditions 2 Health News:Noblis Insights Panel Finds Growing Interest in Hospital Affiliation as a Strategic Response to Challenging Market Conditions 3 Health News:Weizmann Institute scientists show white blood cells move like millipedes 2 Health News:Women More Likely to Experience Non-Traditional Stroke Symptoms 2 Health News:Women More Likely to Experience Non-Traditional Stroke Symptoms 3 Health News:Instrumentation Laboratory Wins Patent Infringement and Unfair Competition Trial Against Diagnostica Stago Relating to Reagents for Hemostasis Diagnostics 2 Health News:Instrumentation Laboratory Wins Patent Infringement and Unfair Competition Trial Against Diagnostica Stago Relating to Reagents for Hemostasis Diagnostics 3

Guardian Highlights Significance of Critical Illness Insurance During National Stroke Awareness Month Dermatologists Encourage People to Screen the One You Love for Skin Cancer Noblis Insights Panel Finds Growing Interest in Hospital Affiliation as a Strategic Response to Challenging Market Conditions Weizmann Institute scientists show white blood cells move like millipedes Women More Likely to Experience Non-Traditional Stroke Symptoms Instrumentation Laboratory Wins Patent Infringement and Unfair Competition Trial Against Diagnostica Stago Relating to Reagents for Hemostasis Diagnostics

Whistle-tip Ureteral Catheters (Left Ureter)

Whistle-tip

40 Angled Tip Ureteral Catheter Set

20 Angled Tip Ureteral Catheter Set

Medicine Products:

Whistle-tip Ureteral Catheters (Left Ureter)Whistle-tip 40 Angled Tip Ureteral Catheter Set 20 Angled Tip Ureteral Catheter Set

First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome ...( Partners Analyze Jatropha Genome and ...),Health